Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
6.07
-0.02 (-0.33%)
Apr 29, 2026, 9:49 AM EDT - Market open
Xeris Biopharma Holdings Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,047 | 1,303 | 505 | 325 | 181 | 365 | |
| Market Cap Growth | 72.13% | 157.72% | 55.70% | 79.47% | -50.50% | - | |
| Enterprise Value | 1,189 | 1,469 | 707 | 487 | 226 | 360 | |
| Last Close Price | 6.09 | 7.85 | 3.39 | 2.35 | 1.33 | 2.93 | |
| PE Ratio | 1895.85 | 2351.09 | - | - | - | - | |
| Forward PE | 51.74 | 64.50 | - | - | - | - | |
| PS Ratio | 3.57 | 4.46 | 2.49 | 1.98 | 1.64 | 7.37 | |
| PB Ratio | 73.95 | 95.15 | -17.07 | -47.86 | 4.00 | 3.84 | |
| P/FCF Ratio | 37.29 | 46.64 | - | - | - | - | |
| P/OCF Ratio | 36.38 | 45.50 | - | - | - | - | |
| EV/Sales Ratio | 4.07 | 5.03 | 3.48 | 2.97 | 2.05 | 7.26 | |
| EV/EBITDA Ratio | 32.08 | 39.64 | - | - | - | - | |
| EV/EBIT Ratio | 47.74 | 58.99 | - | - | - | - | |
| EV/FCF Ratio | 42.55 | 52.58 | - | - | - | - | |
| Debt / Equity Ratio | 18.85 | 18.85 | -9.17 | -33.79 | 4.38 | 0.93 | |
| Debt / EBITDA Ratio | 5.73 | 5.73 | - | - | - | - | |
| Debt / FCF Ratio | 9.24 | 9.24 | - | - | - | - | |
| Net Debt / Equity Ratio | 10.74 | 10.74 | -6.75 | -23.11 | 1.68 | -0.15 | |
| Net Debt / EBITDA Ratio | 3.97 | 3.97 | -9.26 | -4.95 | -1.09 | 0.14 | |
| Net Debt / FCF Ratio | 5.27 | 5.27 | -5.28 | -3.18 | -0.74 | 0.15 | |
| Asset Turnover | 0.83 | 0.83 | 0.63 | 0.49 | 0.34 | 0.21 | |
| Inventory Turnover | 0.73 | 0.73 | 0.85 | 0.90 | 1.06 | 1.01 | |
| Quick Ratio | 1.48 | 1.48 | 1.12 | 1.17 | 2.08 | 1.52 | |
| Current Ratio | 2.19 | 2.19 | 1.67 | 1.64 | 2.54 | 1.80 | |
| Return on Equity (ROE) | - | - | - | -324.20% | -134.83% | -190.28% | |
| Return on Assets (ROA) | 4.40% | 4.40% | -6.51% | -8.25% | -15.78% | -28.45% | |
| Return on Capital Employed (ROCE) | 9.10% | 9.10% | -15.10% | -19.40% | -30.20% | -46.80% | |
| Earnings Yield | 0.05% | 0.04% | -10.85% | -19.18% | -52.34% | -33.59% | |
| FCF Yield | 2.68% | 2.14% | -7.49% | -15.18% | -57.18% | -26.44% | |
| Buyback Yield / Dilution | -17.69% | -17.69% | -6.61% | -1.51% | -71.62% | -85.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.